Ursprung des Netzwerks ersten Grades von John D. O'Neill
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Xylyx Bio, Inc.
Xylyx Bio, Inc. Pharmaceuticals: MajorHealth Technology Xylyx Bio, Inc. provides drug discovery and development services for patients. The company is based in Brooklyn, NY. The company was founded in 2016 by Gordana Vunjak-Novakovic, John D. O'Neill. The CEO is Andrea Nye.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von John D. O'Neill
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Dover Group, Inc. | Founder | ||
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology AZTherapies, Inc. engages in the development of therapeutics for Alzheimer’s disease and ischemic stroke treatments. Its product pipelines include ALZT-OP1, ALZT-OP2, AZHALER-D, and ALZT-QoL. The company was founded by David R. Elmaleh in 2011 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Corporate Officer/Principal | |
Fairleigh Dickinson University | College/University | Undergraduate Degree | |
University of Belgrade | College/University | Graduate Degree | |
IQuum, Inc.
IQuum, Inc. Pharmaceuticals: MajorHealth Technology IQuum, Inc. designs and develops biological molecular diagnostics products. It develops lab-in-a-tube technology, a novel biological sample testing platform which provides revolutionary benefits to a broad cross section of the bioassay market. The firm''s proprietary technology enables the non-specialized personnel to perform more sophisticated biological sample testing in any setting with greater speed. The company was founded by Shuqi Chen and Keith Greenfield in 1998 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Founder | |
Sight Code, Inc. | Director/Board Member | ||
Zebra Pharmaceuticals, Inc. | Director/Board Member | ||
The Doe Fund, Inc.
The Doe Fund, Inc. Services to the Health IndustryHealth Services The Doe Fund, Inc. provides programs and support services for homeless people. The private company is based in New York, NY. | Services to the Health Industry | Director/Board Member | |
Columbia Business School | College/University | Masters Business Admin | |
TARA Biosystems, Inc.
TARA Biosystems, Inc. Packaged SoftwareTechnology Services TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY. | Packaged Software | Founder | |
Spruce Technology, Inc.
Spruce Technology, Inc. Packaged SoftwareTechnology Services Spruce Technology, Inc provides information technology solutions and services. Its solutions include Microsoft practice, licensing practice, enterprise resource planning, enterprise content management, project delivery, and business solutions. The firm also provides advisory, professional, and strategic staffing services. Spruce Technology was founded in 2006 and is headquartered in Clifton, NJ. | Packaged Software | Chief Executive Officer | |
Matritek, Inc.
Matritek, Inc. BiotechnologyHealth Technology Matritek, Inc. develops tissue specific biomaterials. It offers biomaterial products in the areas of bladder, blood vessel, bone, brain, cartilage, chorion, esophagus, fat, heart, kidney, large intestine, larynx, liver, lung, microvasculature, muscle, pancreas, skin, small intestine, spleen, stomach, thymus, umbilical cord, and other organs. The company was founded by John O'Neill and Sue Halligan in 2016 and is headquartered in New York, NY. | Biotechnology | Founder | |
EpiBone, Inc.
EpiBone, Inc. Medical SpecialtiesHealth Technology Epibone, Inc. develops bone reconstruction solutions. Its technology utilizes a scan of the patient?s bone defect and the patient?s own stem cells to construct and cultivate an autologous-like bone graft that provides defect repair, and improves bone formation and regeneration. The company was founded by Nina Tandon, Gordana Vunjak-Novakovic, Sarindr Bhumiratana, Sidney Eisig, and Elisa Cimetta and is headquartered in Brooklyn, NY. | Medical Specialties | Founder | |
NanoTomer, Inc.
NanoTomer, Inc. Miscellaneous Commercial ServicesCommercial Services NanoTomer, Inc. provides bio technology services. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Catalio Capital Management LP
Catalio Capital Management LP Investment ManagersFinance Catalio Capital Management LP (Catalio Capital) is a venture capital firm founded in 2020 by George Petrocheilos and Dr. Jacob Vogelstein. The firm is headquartered in New York. | Investment Managers | Private Equity Investor | |
PhageNova Bio, Inc.
PhageNova Bio, Inc. BiotechnologyHealth Technology PhageNova Bio, Inc. is a biotechnology company that is developing a modular, bacteriophage-based platform for targeted gene expression in cancer, vaccination, and molecular imaging. PhageNova Bio is based in Scarsdale, NY. The company's lead cancer construct is designed to selectively target tumor-associated blood vessels and tumor cells, resulting in the expression of TNF-?, an anti-tumor agent, specifically and exclusively in tumors. The company has extensively validated tumor targeting and selective gene expression capabilities, and therapeutic efficacy was observed in the absence of dose-limiting toxicity in multiple species and several tumor models. The company was founded by Renata Pasqualini, Wadih Arap, Steven K. Libutti, Juri G. Gelovani, and the CEO is Jason A. Rifkin. | Biotechnology | Director/Board Member | |
Immplacate, Inc.
Immplacate, Inc. Miscellaneous Commercial ServicesCommercial Services Immplacate, Inc. is an American company that focuses on researching and developing cell therapies and related products to improve the quality of life for patients with immune disorders. The company was founded by Gordana Vunjak-Novakovic and Holly Wobman, and the CEO is Anthony A Curro. | Miscellaneous Commercial Services | Founder Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 19 |
Serbien, Republik | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 5 |
Technology Services | 3 |
Commercial Services | 3 |
Non-Energy Minerals | 2 |
Operativ
Director/Board Member | 14 |
Founder | 7 |
Corporate Officer/Principal | 4 |
Chief Executive Officer | 3 |
Undergraduate Degree | 2 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- John D. O'Neill
- Unternehmensverbindungen